SEATTLE and VANCOUVER, British Columbia, July
28, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc.
(Nasdaq: ACHV), a clinical-stage pharmaceutical company
committed to the global development and commercialization
of cytisinicline for smoking cessation and nicotine
addiction, today announced that it will report its second
quarter 2020 financial results on Thursday, August 6, 2020.
Company management will host a conference call and live webcast at
4:30 pm Eastern Time to report
financial results and provide an update on the cytisinicline
clinical development program.
To access the webcast, log on to the Investor Relations page of
the Achieve website at
Alternatively, you may access the live conference call by dialing
(877) 472-9809 (U.S. & Canada)
or (629) 228-0791 (International) and
referencing conference ID 1661409. A webcast
replay will be available approximately two hours after the call and
will be archived on the website for 90 days.
(415) 375-3340 ext. 4
View original content to download
SOURCE Achieve Life Sciences, Inc.